Internal Medicine, Hematology & Oncology · Warren, OH
NPI
1073517835
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1745 Niles Cortland Rd NE Ste 5
Warren, OH, 44484
Phone (330) 856-8600
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.1M
196,655 services
Medicare patients, 2024
375
Average age 76
Drug cost, 2024
$9.1M
3,268 prescriptions
Company payments, 2025
$1,328
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lori C Hemrock was code J1439 (injection, ferric carboxymaltose, 1 mg), 31,600 times for 24 patients. In total Lori C Hemrock billed 196,655 services in 100 codes, and Medicare paid $4.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 31,600 | 24 | $0.86 | $27K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 28,600 | 18 | $44.70 | $1.3M |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 19,380 | 16 | $2.16 | $42K |
| J0185 Injection, aprepitant, 1 mg | Office | 10,400 | 19 | $1.34 | $14K |
| J0897 Injection, denosumab, 1 mg | Office | 9,360 | 20 | $20.61 | $193K |
| Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | Office | 3,390 | 11 | $31.33 | $106K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,621 | 42 | $0.09 | $234 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,110 | 17 | $0.25 | $278 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 790 | 19 | $0.71 | $564 |
| 96367 Intravenous Infusion, Hydration | Office | 549 | 48 | $20.99 | $12K |
| 96372 Injection Administration | Office | 433 | 59 | $10.38 | $4,495 |
| 96413 Chemotherapy Administration | Office | 396 | 52 | $93.66 | $37K |
| J9045 Injection, carboplatin, 50 mg | Office | 389 | 12 | $2.85 | $1,109 |
| 99214 Office E&M - Established | Office | 318 | 169 | $94.33 | $30K |
| 96375 Injection Administration | Office | 258 | 40 | $11.31 | $2,917 |
By year: 2022 $2.8M for 148,324 services; 2023 $3.4M for 155,053 services; 2024 $4.1M for 196,655 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lori C Hemrock prescribed most often to Medicare patients was Anastrozole, with 352 prescriptions and refills. In total Lori C Hemrock wrote 3,268 Medicare prescriptions that cost $9.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 352 | 858 | 84 | $6,415 |
| Prednisone Generic | 160 | 185 | 55 | $530 |
| Ondansetron Hcl Generic | 152 | 157 | 61 | $3,670 |
| Pantoprazole Sodium Generic | 135 | 223 | 44 | $1,010 |
| Gabapentin Generic | 106 | 153 | 24 | $1,066 |
| Xtandi Enzalutamide | 93 | 93 | 11 | $1.2M |
| Letrozole Generic | 75 | 164 | 19 | $1,450 |
| Lenalidomide Generic | 70 | 70 | Under 11 | $985K |
| Tamoxifen Citrate Generic | 67 | 152 | 14 | $1,478 |
| Eliquis Apixaban | 65 | 83 | 15 | $48K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 63 | 71 | Under 11 | $343K |
| Dexamethasone Generic | 62 | 76 | 29 | $1,192 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 59 | 59 | 19 | $1,319 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 58 | 58 | Under 11 | $543K |
| Aranesp Darbepoetin Alfa In Polysorbat | 54 | 54 | Under 11 | $111K |
Brand drugs: 913 claims; generic drugs: 2,355 claims; opioid claims: 215.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lori C Hemrock $1,328 ($1,328 in general payments such as food, travel and fees) from 30 companies. The largest payer was Abbvie Inc. with $130.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 5 | $130 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $121 |
| Pfizer Inc. PFE | 5 | $102 |
| Janssen Biotech, Inc. JNJ | 4 | $90.89 |
| ASD Specialty Healthcare, LLC | 1 | $81.63 |
| Genentech USA, Inc. ROG.SW | 3 | $67.67 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $65.57 |
| Gilead Sciences, Inc. GILD | 3 | $64.95 |
| GlaxoSmithKline, LLC. GSK | 3 | $64.3 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $62.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.